So ResMed systems will be selling as quickly as they can produce them. Eventually over many months (or years), Philips will have modified/replaced all the faulty systems out there, and will be able to claim that they still have a near-50% market share even though many of those older modified/replaced systems may be sitting on a shelf unused, or kept as a backup system - because current users needed to act immediately to obtain a replacement, as per the Philips Recall directive.
At the moment though, it's certainly not going well for Philips recalled systems users, Philips DMEs, sleep labs, hospitals, etc., that are/were using Philips recalled systems. Philips must be analyzing in detail the recalled registration database to gain insight on the quantity and variety of Philips recalled systems. They're going to need a lot of various new foam components.
Will
Philips ever ask themselves:
"Why are we modifying/replacing these older systems in the future,
after we've already told users to
immediately get new replacement systems?"
The answer could be quite simple. Philips may have strategized that their inability to provide an immediate solution likely would cause them to lose almost all its current PAP systems user base
permanently - except those with a DreamStation 2. Recalled system users had to buy something, and it likely wasn't a new DreamStation 2. Therefore, Philips would only desire to provide past end-users with the least costly solution for Philips. They'll then have their real customers (the DMEs) focus on attracting NEW end-users (and those with DreamStation 2s).
Therefore, Philips has little motivation to provide the fix/replacement any faster. This process could take a very long time to resolve, in which case those receiving their "fix" eventually will not see it as a resolution for their financial costs, anxiety and quiet possibly, they future illnesses.